View Post

Clinical breast exam may not be needed for follow-up

In In The News by Barbara Jacoby

By: Amerigo Allegretto From: auntminnie.com Less than 3% of early-stage breast cancer patients experience disease recurrence during five years of follow-up, and recurrence is more likely to be detected through mammography or patient symptoms than through physical clinical breast exams, a study published June 28 in Clinical Breast Cancer found. Researchers led by Dr. Grace Makari-Judson from Baystate Medical Center in …

View Post

Early Stage HER2+ Breast Cancer: Overview of Adjuvant Treatment

In In The News by Barbara Jacoby

By: Andrew D. Seidman, MD, Vijayakrishna Gadi, MD, PhD, Tiffany A. Traina, MD, William J. Gradishar, MD, Stephanie L. Graff, MD From: onclive.com Transcript: Andrew Seidman, MD: Hello, and welcome to this OncLive® Peer Exchange® titled “Updates in the Treatment of HER2+ and HER2-Low Breast Cancer.” I’m Dr Andrew Seidman from Memorial Sloan Kettering Cancer Center in New York [New …

View Post

European Commission Approves Keytruda in Early-Stage Triple-Negative Breast Cancer

In In The News by Barbara Jacoby

By: Staff Reporter From: precisiononcologynews.com Merck said Tuesday that the European Commission approved its anti-PD-1 therapy Keytruda (pembrolizumab) as a treatment for earlier stages of triple-negative breast cancer. Keytruda is already available in Europe for locally recurrent, unresectable or metastatic TNBC. The new approval will allow TNBC patients with locally advanced or early-stage disease to use Keytruda and chemo before …

View Post

Rare Patient Voice Research opportunity for Early Stage Breast Cancer Patients

In Paid Opportunities For The Cancer Community by Barbara Jacoby

Details: 20 min online online survey Please sign up at the link below to receive an email invite to the survey.  Compensation $35 Now accepting Residents from ALL Countries!! * Companies have finally realized the REAL EXPERTS are the Patients and Caregivers! * Better products, services, and treatments, Start with Better Research. They need YOUR input and are willing to …

View Post

Survival and Surgery-to-Radiotherapy Intervals Among Asian American and Pacific Islander Women With Early Breast Cancer

In In The News by Barbara Jacoby

By: Matthew Stenger From:  ascopost.com In a study reported in JCO Oncology Practice, Taparra et al identified differences in 10-year survival and surgery-to-radiotherapy intervals among disaggregated Asian American and Native Hawaiian/other Pacific Islander women with early-stage breast cancer. The study used National Cancer Database data on 578,927 women diagnosed with stage 0 to II breast cancer between 2004 and 2017. …

View Post

Neoadjuvant and Adjuvant Therapy Elicit Similar Efficacy in Early-Stage HER2+ Breast Cancer

In In The News by Barbara Jacoby

By: Chris Ryan From: onclive.com Neoadjuvant therapy generated similar benefits to adjuvant therapy in patients with early-stage, HER2-positive breast cancer treated in China, suggesting that neoadjuvant therapy should be used in this patient population, according to data from a real-world retrospective study published in The Breast.1 At a median follow-up of 54.1 months (interquartile range, 40.8-68.9), all patients treated with …

View Post

Risk of Early-Stage Breast Cancer Recurring 10 or More Years After Diagnosis Linked to Estrogen Receptor Status, Other Factors

In In The News by Barbara Jacoby

By: Jamie DePolo From: breastcancer.org The risk of early-stage breast cancer coming back (recurring) 10 or more years after diagnosis is linked to a number of factors, including the size of the cancer, the number of lymph nodes that contain cancer, and whether the cancer is estrogen receptor-positive, according to a Danish study. Overall, the study found that recurrence happened …

View Post

FDA Grants Breakthrough Designation for Early-Stage Breast Cancer Detection Blood Test Developed

In In The News by Barbara Jacoby

Source: Datar Cancer Genetics From: prnewswire.com TriNetra™ is a Circulating Tumor Cell detection blood test which is able to identify early-stage Breast Cancer with high accuracy in women above the age of 40 years BOSTON, Nov. 19, 2021 /PRNewswire/ — Datar Cancer Genetics Inc, a leading cancer research company focussed on early detection of cancers today announced that the US Food and …

View Post

Understanding Radiation Therapy as a Patient with Breast Cancer

In In The News by Barbara Jacoby

By: Colleen Moretti From: curetoday.com Being informed and educated may help patients with breast cancer make a treatment decision and feel less afraid. There are many treatment options for patients with breast cancer, and it is important stay informed to understand all of the options and their benefits and side effects, according to an expert. Dr. Ana Botero, a radiation …

View Post

Inbiomotion’s MAF Test® selects breast cancer patients benefitting from adjuvant clodronate, significantly improving their overall survival

In Clinical Studies News by Barbara Jacoby

Source: Inbiomotion From: prnewswire.com – Level 1 evidence from the MAF Test® analyses of the NSABP-B34 landmark clinical trial confirmed clinical utility of the MAF Test® for selection of early-stage breast cancer patients that benefit from adjuvant clodronate treatment to prevent metastasis – Data published in Journal of National Cancer Institute, Cancer Spectrum – MAF-negative status of patients who were …